Vimarsana
Biggest News Aggregation in the World

Robertc Moen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robertc Moen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robertc Moen Today - Breaking & Trending Today

Copernicus Therapeutics: Newly Presented Preclinical Data Shows Potential for Novel Gene Therapy To Treat Opioid Use Disorder - Second Year of NID/ANIH Grant Support Will Enable Further Exploration of Hypothesis - Vimarsana News

Copernicus Therapeutics: Newly Presented Preclinical Data Shows Potential for Novel Gene Therapy To Treat Opioid Use Disorder - Second Year of NID/ANIH Grant Support Will Enable Further Exploration of Hypothesis

Dr. Barbara Waszczak, Professor of Pharmacology at Northeastern University's Bouvé College of Health Sciences, and collaborators from Cummings School of Veterinary Medicine at Tufts University and Tufts

Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder - Vimarsana News

Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder

Dr. Barbara Waszczak, Professor of Pharmacology at Northeastern University's Bouvé College of Health Sciences, is the Principal Investigator and Project...

Rhythm Therapeutics, Inc. Awarded $3.67 million NIH SBIR Fast Track Grant to Develop Gene Therapy for Atrial Fibrillation - Vimarsana News

Rhythm Therapeutics, Inc. Awarded $3.67 million NIH SBIR Fast Track Grant to Develop Gene Therapy for Atrial Fibrillation

Rhythm Therapeutics, Inc. Awarded $3.67 million NIH SBIR Fast Track Grant to Develop Gene Therapy for Atrial Fibrillation Share Article Chicago-based Rhythm Therapeutics is led by founder Dr. Rishi Arora, Professor of Medicine, Clinical Cardiac Electrophysiology at Northwestern University - The Feinberg School of Medicine; Grant is from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, and from the Small Business Innovation Research program that can total up to $3.67 million; Atrial fibrillation is the most common heart rhythm disorder, affectin...

Source: prweb.com